Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease
Violeta Raverdy, Federica Tavaglione, Estelle Chatelain, et al.
Nature Medicine (2024) Vol. 30, Iss. 12, pp. 3624-3633
Open Access | Times Cited: 12

Showing 12 citing articles:

Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment
Norbert Stefan, Hannele Yki‐Järvinen, Brent A. Neuschwander‐Tetri
The Lancet Diabetes & Endocrinology (2024)
Open Access | Times Cited: 16
Metabolic Dysfunction-Associated Steatotic Liver Disease and the Cardiovascular System
Antonis A. Manolis, Theodora A. Manolis, Apostolos Vouliotis, et al.
Trends in Cardiovascular Medicine (2025)
Closed Access | Times Cited: 4
Glucagon like peptide-1 (GLP-1) agonists and cardiometabolic protection: historical development and future challenges
Francisco Westermeier, Enrique Z. Fisman
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 1
MASLD as a non-communicable disease
Silvia Sookoian, Carlos J. Pirola, Arun J. Sanyal
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Fatty Liver Index vs. Biochemical–Anthropometric Indices: Diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease with Non-Invasive Tools
Selim Demirci, Semih Sezer
Diagnostics (2025) Vol. 15, Iss. 5, pp. 565-565
Open Access
Clusters of metabolic dysfunction-associated steatotic liver disease for precision medicine
Norbert Stefan, Giovanni Targher
Nature Reviews Gastroenterology & Hepatology (2025)
Closed Access
Subtypes of MASLD confer distinct clinical trajectories
Panu K. Luukkonen
Journal of Hepatology (2025)
Closed Access
Low HDL cholesterol levels in women and hypertriglyceridemia in men: predictors of MASLD onset in individuals without steatosis
Tsubasa Tsutsumi, Takumi Kawaguchi, Hideki Fujii, et al.
Journal of Gastroenterology (2025)
Closed Access
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Exploring Systemic Impacts and Innovative Therapies
Parag Jain, Akanksha Jain, Rohitas Deshmukh, et al.
Clinics and Research in Hepatology and Gastroenterology (2025), pp. 102584-102584
Closed Access
Fat, fibrosis, and the future: navigating the maze of MASLD/MASH
Scott L. Friedman
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
Familial Combined Hyperlipidemia: Myth or Reality?
Martijn C.G.J. Brouwers, Boudewijn Klop, Josep Ribalta, et al.
Current Atherosclerosis Reports (2025) Vol. 27, Iss. 1
Open Access
Antifibrotic Therapies for Metabolic Dysfunction-associated Steatotic Liver Disease
Robert F. Schwabe, Frank Tacke, Atsushi Sugimoto, et al.
JHEP Reports (2025), pp. 101421-101421
Open Access
Page 1

Scroll to top